Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Results
Phase 2
This trial looked at different combinations of drugs before a stem cell transplant.
It was for people who were having a stem cell transplant with somebody else’s cells. This is an .
This trial was open for people to join between 2013 and 2017. The team published the results in 2020.
Recruitment start: 1 October 2013
Recruitment end: 28 February 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Charles Craddock
Blood Cancer UK
Cure Leukaemia
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Birmingham
Last reviewed: 9 May 2022
CRUK internal database number: 10590